Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences EPS Diluted (Quarterly) : -3.432 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.432 |
| June 30, 2026 | -2.890 |
| March 31, 2026 | -5.289 |
| December 31, 2025 | -1.464 |
| September 30, 2025 | -39.49 |
| June 30, 2025 | -0.7385 |
| March 31, 2025 | -3.914 |
| December 31, 2024 | 1.457 |
| September 30, 2024 | -2.004 |
| June 30, 2024 | -3.687 |
| March 31, 2024 | -4.328 |
| December 31, 2023 | -4.793 |
| September 30, 2023 | -23.53 |
| June 30, 2023 | -12.83 |
| March 31, 2023 | -447.41 |
| December 31, 2022 | -23.21 |
| September 30, 2022 | -33.80 |
| June 30, 2022 | -43.13 |
| March 31, 2022 | -41.84 |
| Date | Value |
|---|---|
| December 31, 2021 | -34.75 |
| September 30, 2021 | -36.51 |
| June 30, 2021 | -63.45 |
| March 31, 2021 | -55.04 |
| December 31, 2020 | -79.06 |
| September 30, 2020 | -82.06 |
| June 30, 2020 | -98.40 |
| March 31, 2020 | -102.35 |
| December 31, 2019 | -132.17 |
| September 30, 2019 | -139.40 |
| June 30, 2019 | -164.84 |
| March 31, 2019 | -190.99 |
| December 31, 2018 | -157.88 |
| September 30, 2018 | -149.63 |
| June 30, 2018 | -152.16 |
| March 31, 2018 | -129.18 |
| December 31, 2017 | -141.30 |
| September 30, 2017 | -128.68 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Q32 Bio, Inc. | -0.2622 |
| IRulya Therapeutics, Inc. | -2.311 |
| Climb Bio, Inc. | -0.1821 |
| PepGen Inc. | -0.28 |
| Bridgebio Oncology Therapeutics, Inc. | -0.4262 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.42M |
| Total Expenses (Quarterly) | 46.42M |
| Enterprise Value | 1.011B |
| Earnings Yield | -41.31% |
| Normalized Earnings Yield | -41.31 |